Tilray Brands Inc. closed $1.79 below its 52-week high ($2.97), which the company reached on April 4th.

Shares of Tilray Brands Inc. TLRY slipped 4.07% to $1.18 Monday, on what proved to be an all-around mixed trading session for ...

Tilray's shares plunge 10% on revenue miss and cash burn concerns, risking further dilution and potential reverse split below ...

Any investor hoping to reap the rewards by holding marijuana companies must be a shiny-eyed optimist at this point. Weed ...

Tilray Brands' upcoming fiscal Q2 results are expected to show revenue growth. Check out why I think investors should avoid ...

Q2 2025 Earnings Call Transcript January 9, 2025 Operator: Thank you for joining us for today’s conference call to discuss ...

Tilray Brands ( TLRY -11.88%) stock tumbled 12% through 9:50 a.m. ET after missing analyst sales forecasts in its Friday ...

Shares of Tilray Inc (NASDAQ:TLRY – Get Free Report) dropped 4.1% during mid-day trading on Monday following a weaker than expected earnings announcement. The stock traded as low as $1.16 and last ...

Tilray Brands reported 9% YoY revenue growth in Q2 2025 to $210.95 million. Fiscal 2025 guidance remains strong at $950 ...

One of the larger players on the pot market is Tilray Brands (NASDAQ: TLRY), and its difficult 2024 mirrored the woes of the cannabis sector in general. Let's do a flyby. Tilray's major story ...

Analyst Robert Moskow of TD Cowen maintained a Buy rating on Tilray (TLRY – Research Report), with a price target of $1.50.Stay Ahead of the ...

Tilray cultivates and sells cannabis in Canada and exports into the global medical market. It also sells CBD and alcohol. The company is the result of legacy Aphria acquiring legacy Tilray in a ...